The Motley Fool··Seena HassounaAdaptive Biotech President Sells $1.2M in Stock, But Bullish Stance Remains Intact
Adaptive Biotechnologies' president sold $1.21M in shares via pre-planned transaction, yet retains substantial holdings. Stock up 51% annually as core MRD business surges.
ADPTbiotechnologyinsider sale